39 citations
,
October 2010 in “Journal of The American Academy of Dermatology” This study reported that alopecia occurred in 2.5% of patients with mycosis fungoides or Sézary syndrome, with some cases resembling alopecia areata and others associated with specific skin lesions.
20 citations
,
June 1964 in “Archives of Dermatology” This study described three cases of follicular mucinosis and observed that one case responded rapidly to systemic corticosteroids, suggesting a potential therapeutic effect.
5 citations
,
January 2024 in “Therapeutic Advances in Hematology” This report suggests an association between eosinophilic folliculitis and sustained complete response in a Sézary syndrome patient treated with mogamulizumab, although regular monitoring is necessary to prevent relapse.
July 2019 in “Zenodo (CERN European Organization for Nuclear Research)” This case report highlights a rare instance of follicular mucinosis in a 15-year-old male, emphasizing its self-limiting, benign course but noting the need for long-term monitoring due to potential association with mycosis fungoides.
February 2025 in “Journal of the European Academy of Dermatology and Venereology” In this study, researchers found that mogamulizumab-associated rashes and alopecia are common in patients treated for mycosis fungoides and Sézary syndrome and may be linked with a good treatment response.